Holmen Bob
SEC CIK 1843508 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FTH | Faeth Therapeutics, Inc. | Dir | 25.6K | — | — | 2 | 2022-06-10 | 2023-07-10 |
Most active insiders at FTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| 2 | STEPHENSON BRIAN C | CFO | $1.13M | — |
| 3 | Peyer James | 10%, See remarks below | — | $787.8K |
| 4 | Cambrian BioPharma Inc | 10% | — | $787.8K |
| 5 | Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| 6 | Hahn Stephen M. | Dir | — | — |
Holmen Bob made no open-market trades at FTH in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-12 | 2023-07-10 | FTH | Faeth Therapeutics, Inc. | Holmen Bob | Dir | A - Grant | $0.00 | +4,466 | 25.6K | +21% | $0 |
| D | 2022-06-14 | 2022-06-10 | FTH | Faeth Therapeutics, Inc. | Holmen Bob | Dir | A - Grant | $0.00 | +4,466 | 21.1K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations